Immucell ICCC
NASDAQ ICCC
$10.06 -0.03 (-0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

Immucell (ICCC) Sales of Property, Plant and Equipment (2015 - 2025)

Immucell (ICCC) Sales of Property, Plant and Equipment (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.85 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 698,426.11
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Immucell 91.19 Mn 82.33 Mn 2.44 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 5,000.00
Dec 31, 2025 5,000.00
Sep 30, 2025 1,900.00
Sep 30, 2025 1,900.00
Sep 30, 2023 2,383.00
Sep 30, 2023 2,383.00
Jun 30, 2023 76.00
Jun 30, 2023 76.00
Mar 31, 2023 15.00
Mar 31, 2023 15.00
Mar 31, 2022 11,000.00
Mar 31, 2022 11,000.00
Dec 31, 2021 1,315.00
Dec 31, 2021 1,315.00
Sep 30, 2021 3,975.00
Sep 30, 2021 3,975.00
Mar 31, 2021 10,000.00
Mar 31, 2021 10,000.00
Dec 31, 2020 45,000.00
Dec 31, 2020 45,000.00